AMY BURGER: Open Payments
NPI 1790114114 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,513 in 150 payments from 27 companies in 2025. Trend: 2023 $3,092 · 2024 $3,472 · 2025 $3,513
Food & beverage: $3,513
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 31 | $592 |
| Dendreon Pharmaceuticals LLC | 17 | $526 |
| Janssen Biotech, Inc. | 10 | $260 |
| Endo USA, Inc. | 13 | $235 |
| PFIZER INC. | 10 | $206 |
| Antares Pharma, Inc. | 9 | $200 |
| Boston Scientific Corporation | 3 | $198 |
| Medtronic, Inc. | 6 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $190 |
| Ferring Pharmaceuticals Inc. | 8 | $150 |
Products named: PROVENGE, GEMTESA, XTANDI, ERLEADA, ORGOVYX, XYOSTED, INTERSTIM, Nubeqa.
Industry payments across NC — which companies pay providers there.
